95% overall response rate observed in relapsed/refractory multiple myeloma patients not previously treated with BCMA-targeted therapy98% overall response rate observed…
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced that RC Consulting Group LLC…
The two full day event, Longevity Investors Conference, held in Gstaad, featured a diverse array of speakers, including leading scientists,…
VANCOUVER, BC / ACCESSWIRE / November 6, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTFF)(FSE:BXT) is pleased to…
NEW YORK, NY / ACCESSWIRE / November 6, 2023 / Laxxon Medical announced today its participation in the 29th annual…
- Patients in OPTIC continue to experience long-term benefit from Ixo-vec through 3 years of follow-up, including maintenance of vision,…
SYFOVRE reduced nonsubfoveal GA lesion growth by over 40% (monthly) in Year 3 compared to projected sham in the GALE…
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced the issuance of the underlying…
Mississauga, Ontario--(Newsfile Corp. - November 3, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in…
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)…